Abstract
Abstract Pre-exposure prophylaxis (PrEP) became publicly available in Quebec for gay, bisexual and other men who have sex with men (GBM) in 2013. We used baseline data from Engage, a cohort of GBM recruited by respondent-driven sampling, to examine patterns of combination HIV prevention use among Montreal GBM since PrEP became available. Latent class analysis, stratified by HIV status, was used to categorize GBM by self-reported use of biomedical and behavioural prevention strategies. Correlates of resulting classes were identified using multinomial logistic regression. Among HIV-negative/unknown GBM (n = 968), we identified four classes: low use of prevention (32%), condoms (40%), seroadaptive behaviour (21%), and biomedical (including PrEP; 7%). Those using prevention (condoms, seroadaptive behaviour, and biomedical) had a higher number of anal sex partners and were more likely to report a recent sexually transmitted infection diagnosis. GBM using biomedical prevention also had a higher level of formal education. Among GBM living with HIV (n = 200), we identified three classes: mainly antiretroviral treatment (ART) with viral suppression (53%), ART with viral suppression and condoms (19%), and ART with viral suppression and seroadaptive behaviour (18%). Again, the number of anal sex partners was higher among those using condoms and seroadaptive behaviours. Our findings show antiretroviral-based prevention, either alone or in combination with other strategies, is clearly a component of the HIV prevention landscape for GBM in Montreal. Nevertheless, PrEP uptake remains low, and there is a need to promote its availability more widely.
Funder
Canadian Institutes of Health Research
Canadian HIV Trials Network, Canadian Institutes of Health Research
Canadian Foundation for AIDS Research
Ontario HIV Treatment Network
Public Health Agency of Canada
Canadian Blood Services
Ministère de la Santé et des Services sociaux du Quebec
Universities Without Walls
Engage
Fonds de Recherche du Québec - Santé
Réseau du researche en santé des populations du Quebec
Ryerson University
Canada Excellence Research Chairs, Government of Canada
Applied HIV Research Chair, Ontario HIV Treatment Network
Michael Smith Foundation for Health Research
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference84 articles.
1. Haddad N, Robert A, Weeks A, Popovic N, Siu W, Archibald C. HIV in Canada—surveillance report, 2018. Can Commun Dis Rep. 2019;45(12):304–12.
2. Institut national de santé publique du Québec. Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec: Rapport Annuel 2018. Gouvernement du Québec; 2019.
3. Bruemmer R. Montreal joins UNAIDS program to eradicate disease by 2030. Montreal Gazette [Internet]. 2017 [cited 29 April 2019]. Available from: http://montrealgazette.com/news/local-news/montreal-to-join-unaids-program-to-eradicate-disease-by-2030.
4. Montréal signe la Déclaration de Paris visant à l'éradication du VIH/SIDA [press release]. Ville de Montréal, December 1, 2017. Available from: http://ville.montreal.qc.ca/portal/page?_pageid=5798,42657625&_dad=portal&_schema=PORTAL&id=29427
5. Hankins CA, de Zalduondo BO. Combination prevention: a deeper understanding of effective HIV prevention. AIDS (London, England). 2010;24(Suppl 4):S70–80.